Background: There are no evidence-based guidelines for the treatment of neonatal sepsis although standard text books recommend 14 days of antibiotics for blood culture-proven neonatal sepsis. Objective: The present study compared the effectiveness of a 10-day course of antibiotic therapy with the conventional 14-day course in blood culture-proven neonatal sepsis. Methods: Infants !32 weeks and !1.5 kg weight with blood culture-proven sepsis were randomized to either 10-day (study group) or 14-day (control group) therapy on Day 7 of appropriate antibiotic therapy, if they were in clinical remission and were C-Reactive Protein (CRP) negative. The primary outcome was treatment failure within 28 days defined by either positive CRP or positive blood culture or clinical relapse. Results: The baseline characteristics were comparable between the two groups. There was one treatment failure in each group. The duration of hospital stay was significantly shorter in the 10-day treatment group. Conclusion: Ten-day antibiotic therapy is as effective as 14-day therapy in blood culture-proven neonatal sepsis, if the infant has achieved clinical remission by Day 7 of therapy.
Introduction
Current standard text books recommend 14-day antibiotic therapy for culture-proven neonatal sepsis [1] [2] [3] . The rationale and safety of this has, however, never been scientifically evaluated. Recent reports suggest that shorter courses of antibiotic therapy may be as effective as the conventionally recommended longer ones [4] [5] [6] . The present study evaluated the effectiveness of a 10-day course of antibiotic therapy with the conventional 14-day course in blood culture-proven neonatal sepsis.
Materials and Methods
This randomized controlled trial enrolled clinically symptomatic neonates with a gestational age of !32 weeks, a birth weight of !1.5 kg and blood culture-proven sepsis. Babies with birth asphyxia, congenital malformations and those with evidence of deep seated foci of infections, such as meningitis, osteomyelitis, septic arthritis, etc., were excluded.
Those enrolled were randomized to either 10-day (study group) or 14-day (control group) therapy on Day 7 of appropriate antibiotic therapy, if the baby had clinically remitted and was C-Reactive Protein (CRP) negative. CRP and blood culture were repeated at 48 h after stopping antibiotic therapy in all the babies in both groups. An informed consent was obtained from the parents of all babies enrolled and the study was cleared by the hospital ethics committee. All babies were followed up on a weekly basis for a period of 4 weeks.
The primary outcome was treatment failure within 28 days, defined by either positive CRP or positive blood culture growing the same organism as cultured earlier or clinical relapse.
CRP was determined by latex agglutination, semiquantitative method. Agglutination in the highest serum dilution was used to estimate the amount of CRP in milligrams per liter present in test specimen. CRP level of !6 mg l À1 was considered positive. An incubation period of 72 h was taken before labeling the culture as sterile. The persons doing the CRP and blood culture were blinded to the group to which the patient belonged.
The unpaired 't'-test and chi-square test were used for statistical analysis.
Results
During the study period from November 2004 to December 2005, 287 babies who were !32 weeks and !1500 g had blood culture-proven sepsis. Of these, 106 could not be enrolled as 54 had meningitis and 52 died before enrollment. The total number of eligible babies was 181. All these babies received empirically started antibiotics initially (Cefotaxime þ Amikacin), which were revised when blood culture sensitivity report became available. Of the 181 babies enrolled, 96 were symptomatic on Day 7 and were therefore excluded. Out of the remaining 85 babies who were asymptomatic on Day 7, 25 had CRP positive on Day 7 and were therefore excluded. Thus, 60 patients were ultimately randomized to the study (n ¼ 30) and control groups (n ¼ 30).
Baseline characteristics including gestation, birth weight, sex, Apgar score, early-and late-onset sepsis and acute-phase reactants were comparable in the study and control groups ( Table 1) .
The commonest organism causing sepsis was Pseudomonas in both the study (n ¼ 13) and control (n ¼ 18) groups ( Table 2 ). The CRP and blood culture taken 48 h after stopping antibiotic therapy were negative in all babies in both groups implying thereby that antibiotic therapy for 10 days was as effective as 14-day therapy. The duration of stay was significantly lesser in the study group (13.03 þ 1.77 days) compared with the control group (17.5 þ 2.20 days). One subject in the study group was admitted for clinical sepsis on Day 13 after discharge. The CRP was positive but the blood culture was sterile. In the control group too, a baby after 16 days of discharge was brought gasping to the pediatric casualty and although resuscitation was attempted, the baby could not be saved. Although both these cases might have been fresh episodes of sepsis, we have considered them as treatment failure to prevent any possibility of false magnification of the benefits of short-course therapy.
Discussion
Of the 181 babies initially enrolled, only 85 were asymptomatic by Day 7 and out of these 85 asymptomatic babies, 25 babies were still CRP positive on Day 7. In a similar study by Ehls et al. [7] , all 156 neonates became asymptomatic by Day 6 of antibiotic therapy and were also CRP negative by Day 6. But out of these 156 neonates, only 13 were blood culture positive [7] . The possible reason for 29% of our babies still being CRP positive on Day 7 may relate to our technique of CRP estimation i.e. latex agglutination and the fact that a CRP of !6 mg l À1 was considered as positive.
In the study by Jaswal et al. [8] , out of 50 cases (42% culture positive) of suspected neonatal sepsis, 48% were still CRP positive on Day 7 of antibiotic therapy. In a study by Philip et al. [9] , 8 out of 10 cases of group B streptococcal infection became CRP negative by Day 8 of therapy. In our study, on the Day 7 CRP was negative in 60 of the 85 asymptomatic neonates in both groups. Two patients developed treatment failure. Thus, the Day 7 CRP correctly excluded sepsis in 58 out of 60 cases. The negative predictive value of CRP in the index study, therefore, was 96.67%. Similar observations have been made by others [10, 11] . The treatment failure rate in the 10-day treatment group was comparable with that in the 14-day treatment group, even when the criteria used for treatment failure were stricter than those used by other authors [6, 7, 12] . Engle et al. group compared with none in the 7-day treatment group (P > 0.05). Seven-day ceftriaxone therapy has been reported to be as effective as 10-day therapy in bacterial meningitis [5, 13] . The secondary outcome variable in the index study was the mean duration of stay in hospital. This was significantly shorter in the study group compared with the control group (13.03 þ 1.7 days compared with 17.5 þ 2.2 days, P < 0.05). This would imply lesser cost and also a lesser risk of nosocomial sepsis that is likely with longer hospital stay. Thus, we documented that 10-day antibiotic therapy was as effective as 14-day therapy in culture-proven neonatal sepsis if the neonate was in clinical remission and CRP negative on Day 7 of appropriate antibiotic therapy.
However, the study has some limitations. First, the results of our study are valid for the specified group of neonates studied [gestational age (GA) ! 32 weeks and birth weight ! 1.5 kg]. Second, we used semiquantitative latex agglutination method for estimation of CRP. Ideally, a quantitative method such as nephelometry or radioimmunoassay should have been used. Third, the sample size in the study was small. However, results of the present study could form a basis for a larger multicentric trial. 
